The Board of Directors of Kilitch Drugs (India) Limited, in their meeting held on Wednesday, March 25, 2026, approved the allotment of 1,74,80,782 bonus equity shares. These shares, with a face value of Rs. 10 each, were issued in a 1:1 ratio to shareholders holding stock as of the record date, March 24, 2026. This issuance has effectively doubled the company’s paid-up equity share capital from Rs. 174.81 million (pre-bonus) to Rs. 349.62 million (post-bonus).

The allotment follows a prior recommendation by the Board in February 2026 to capitalize reserves for this 1:1 bonus issue, a move aimed at rewarding existing shareholders. The company utilized approximately Rs. 174.81 million from its free reserves and securities premium account to implement this capitalization. These newly allotted bonus shares rank pari-passu in all respects with the existing fully paid-up equity shares of the company.

Established in 1978, Kilitch Drugs (India) Ltd. is a global pharmaceutical company specializing in the manufacturing and marketing of a wide range of formulations, including antibacterials, ophthalmics, and parenteral products. In 2025, the company made significant strides by successfully completing a Rights Issue in August, which was subscribed 1.19 times, raising approximately Rs. 49.93 crores to fund its expansion plans. Furthermore, the company is actively developing a new Greenfield project in Pen, Maharashtra, to produce oral tablets and liquid injectables, with commercial production expected to commence in the 2025-2026 fiscal year.

In its latest reported financial results for the quarter ended December 31, 2025, Kilitch Drugs (India) Ltd. recorded a consolidated revenue of Rs. 55.34 crores, representing a marginal decline of 0.43% from the previous quarter’s Rs. 55.58 crores. The company’s net profit for the same period stood at Rs. 4.43 crores, reflecting a sharp decline of approximately 45.91% compared to the quarter ended September 2025. Noted investor Mukul Mahavir Agrawal is among the prominent shareholders, holding a 1.34% stake in the company as of late 2025.

Leave a Reply

Quote of the week

Do not save what is left after spending; instead spend what is left after saving

~ Warren Buffett

Designed with WordPress

Discover more from Investeepedia

Subscribe now to keep reading and get access to the full archive.

Continue reading